TC-6987

· Targacept Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for TC-6987, covering 2013-09-13 to 2013-09-13. Get the full timeline:

Most recent: Clinical Trial Update: Glycemic Control, Safety and Tolerability of TC-6987 Monotherapy in Type 2 Diabetes Mellitus [Phase 2]